Literature DB >> 10739666

Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization.

N R dos Santos1, D R de Bruijn, E Kater-Baats, A P Otte, A G van Kessel.   

Abstract

In the vast majority of synovial sarcomas the N-terminal part of the SYT protein is fused to the C-terminal part of an SSX protein, either SSX1 or SSX2. The wild-type proteins, as well as the resultant SYT-SSX1 and SYT-SSX2 fusion proteins, are localized in the nucleus. Recent studies in experimental systems indicated that the SYT protein may function as a transcriptional activator whereas the SSX proteins may act as transcriptional repressors. In the present work we created a series of deletion mutants and found that SYT and SSX depend on N-terminal and highly conserved C-terminal domains for nuclear localization, respectively. Our results also show that the SYT-SSX proteins colocalize with SSX2, a feature that depends on the presence of the C-terminal SSX sequences in the chimeric proteins. Absence of these sequences led to an altered subcellular localization, coinciding with that of SYT. Besides, we found that endogenously expressed SSX proteins colocalize with polycomb-group proteins and condensed chromosomes during mitosis, features that are also conferred by the C-terminus of SSX. Taken together, these results led us to conclude that the SSX moiety, especially the most C-terminal 34 amino acids, of the SYT-SSX fusion proteins is crucial for aberrant spatial targeting and transcriptional control within the nucleus. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739666     DOI: 10.1006/excr.2000.4813

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  Subnuclear distribution of SSX regulates its function.

Authors:  Jiaochen Wang; Huali Wang; Wei Hou; Haijing Liu; Yongxin Zou; Hong Zhang; Lin Hou; Michael A McNutt; Bo Zhang
Journal:  Mol Cell Biochem       Date:  2013-05-18       Impact factor: 3.396

2.  The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.

Authors:  Ana Banito; Xiang Li; Aimée N Laporte; Jae-Seok Roe; Francisco Sanchez-Vega; Chun-Hao Huang; Amanda R Dancsok; Katerina Hatzi; Chi-Chao Chen; Darjus F Tschaharganeh; Rohit Chandwani; Nilgun Tasdemir; Kevin B Jones; Mario R Capecchi; Christopher R Vakoc; Nikolaus Schultz; Marc Ladanyi; Torsten O Nielsen; Scott W Lowe
Journal:  Cancer Cell       Date:  2018-03-01       Impact factor: 31.743

Review 3.  Synovial sarcoma: from genetics to genetic-based animal modeling.

Authors:  Malay Haldar; R Lor Randall; Mario R Capecchi
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

Review 4.  The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Authors:  Heath A Smith; Douglas G McNeel
Journal:  Clin Dev Immunol       Date:  2010-10-11

5.  Genome-wide recruitment to Polycomb-modified chromatin and activity regulation of the synovial sarcoma oncogene SYT-SSX2.

Authors:  Christina B Garcia; Christian M Shaffer; Josiane E Eid
Journal:  BMC Genomics       Date:  2012-05-17       Impact factor: 3.969

6.  Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy.

Authors:  Joanna Przybyl; Monika Jurkowska; Piotr Rutkowski; Maria Debiec-Rychter; Janusz A Siedlecki
Journal:  Sarcoma       Date:  2012-03-25

7.  Cancer/testis antigens and gametogenesis: a review and "brain-storming" session.

Authors:  Martins Kalejs; Jekaterina Erenpreisa
Journal:  Cancer Cell Int       Date:  2005-02-16       Impact factor: 5.722

8.  Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells.

Authors:  Padraig D'Arcy; Wessen Maruwge; Barry Wolahan; Limin Ma; Bertha Brodin
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

9.  Cytosolic SYT/SS18 isoforms are actin-associated proteins that function in matrix-specific adhesion.

Authors:  Jaehong Kim; Mei Swee; William C Parks
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

10.  Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.

Authors:  Yasushi Yoneda; Sachio Ito; Toshiyuki Kunisada; Yuki Morimoto; Hirotaka Kanzaki; Aki Yoshida; Kenji Shimizu; Toshifumi Ozaki; Mamoru Ouchida
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.